COVID-19 therapeutics
Since the emergence of COVID-19 in 2020, an unprecedented range of therapeutic options
has been studied and deployed. Healthcare providers have multiple treatment approaches …
has been studied and deployed. Healthcare providers have multiple treatment approaches …
Remdesivir-Induced bradycardia and mortality in SARS-CoV-2 infection, potential risk factors assessment: a systematic review and Meta-Analysis
MY Ai, WL Chang, CJ Yang - Journal of Clinical Medicine, 2023 - mdpi.com
Background: The efficacy of remdesivir in reducing disease severity among COVID-19-
infected patients has been established, but concerns have emerged regarding the potential …
infected patients has been established, but concerns have emerged regarding the potential …
Pharmacokinetics of GS-441524, the active metabolite of remdesivir, in patients receiving continuous renal replacement therapy: A case series
A Nishikawa, I Ito, A Yonezawa, K Itohara… - Journal of Infection and …, 2024 - Elsevier
Remdesivir plays a key role in the treatment of coronavirus disease in 2019 (COVID-19).
Haemodialysis is sometimes required for hospitalised patients with COVID-19, and patients …
Haemodialysis is sometimes required for hospitalised patients with COVID-19, and patients …